Freshworks to Enter S&P SmallCap 600 on October 8
Freshworks will replace BioLife Solutions in the index as Repligen’s acquisition of BioLife nears completion, subject to final closing conditions.
Makkler Newsroom · Oct 6, 02:43 AM · 1 min read
Repligen Corporation RGEN
NASDAQHealth TechnologyUnited States
$167.79+1.27 (+0.76%)
Market closed· · USD · Data may be delayed
- Day's range
- 165.26168.48
- 52-week range
- 100.99198.87
Financial health
– / 5
Analyst view · 23 firms
Buy17 buy · 5 hold · 1 sell
Avg. target $204.50 (+21.9%)
Prices may be delayed and are for informational purposes only - not investment advice.